Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
- PMID: 32784208
- PMCID: PMC7418071
- DOI: 10.1136/bmj.m2724
Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study
Abstract
Objective: To assess temporal trends in the association between newly diagnosed atrial fibrillation and death.
Design: Community based cohort study.
Setting: Framingham Heart Study cohort, in 1972-85, 1986-2000, and 2001-15 (periods 1-3, respectively), in Framingham, MA, USA.
Participants: Participants with no atrial fibrillation, aged 45-95 in each time period, and identified with newly diagnosed atrial fibrillation (or atrial flutter) during each time period.
Main outcome measures: The main outcome was all cause mortality. Hazard ratios for the association between time varying atrial fibrillation and all cause mortality were calculated with adjustment for time varying confounding factors. The difference in restricted mean survival times, adjusted for confounders, between participants with atrial fibrillation and matched referents at 10 years after a diagnosis of atrial fibrillation was estimated. Meta-regression was used to test for linear trends in hazard ratios and restricted mean survival times over the different time periods.
Results: 5671 participants were selected in time period 1, 6177 in period 2, and 6174 in period 3. Adjusted hazard ratios for all cause mortality between participants with and without atrial fibrillation were 1.9 (95% confidence interval 1.7 to 2.2) in time period 1, 1.4 (1.3 to 1.6) in period 2, and 1.7 (1.5 to 2.0) in period 3 (Ptrend=0.70). Ten years after diagnosis of atrial fibrillation, the adjusted difference in restricted mean survival times between participants with atrial fibrillation and matched referents decreased by 31%, from -2.9 years (95% confidence interval -3.2 to -2.5) in period 1, to -2.1 years (-2.4 to -1.8) in period 2, to -2.0 years (-2.3 to -1.7) in period 3 (Ptrend=0.03).
Conclusions: No evidence of a temporal trend in hazard ratios for the association between atrial fibrillation and all cause mortality was found. The mean number of life years lost to atrial fibrillation at 10 years had improved significantly, but a two year gap compared with individuals without atrial fibrillation still remained.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI), Framingham Heart Study, and the Boston University School of Medicine for the submitted work; LF reports grants from the Health Research Foundation of Central Denmark Region, personal fees from Bristol-Myers Squibb, personal fees from Pfizer, personal fees from Bayer, and personal fees from Merck Sharp and Dohme, outside of the submitted work. EJB serves as an uncompensated member of the MyHeartLab Steering Committee. The MyHeartLab Study is a principal investigator initiated study from the University of California San Francisco (UCSF): principal investigator Jeffrey Olgin, through a research grant to UCSF from Samsung. NV, QH, MF-G, and LT have no competing interests.
Figures
Similar articles
-
Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart Study.BMC Med. 2021 Jul 29;19(1):170. doi: 10.1186/s12916-021-02037-x. BMC Med. 2021. PMID: 34320976 Free PMC article.
-
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.Lancet. 2015 Jul 11;386(9989):154-62. doi: 10.1016/S0140-6736(14)61774-8. Epub 2015 May 7. Lancet. 2015. PMID: 25960110 Free PMC article.
-
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999.Int J Cardiol. 2005 Aug 3;103(1):78-84. doi: 10.1016/j.ijcard.2004.08.024. Int J Cardiol. 2005. PMID: 15922465
-
Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.Eur J Prev Cardiol. 2017 Sep;24(14):1555-1566. doi: 10.1177/2047487317715769. Epub 2017 Jun 15. Eur J Prev Cardiol. 2017. PMID: 28617620 Free PMC article. Review.
-
Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.PLoS One. 2018 Mar 8;13(3):e0193924. doi: 10.1371/journal.pone.0193924. eCollection 2018. PLoS One. 2018. PMID: 29518134 Free PMC article. Review.
Cited by
-
An anthropomorphic phantom for atrial transseptal puncture simulation training.3D Print Med. 2024 Oct 30;10(1):34. doi: 10.1186/s41205-024-00241-y. 3D Print Med. 2024. PMID: 39472399 Free PMC article.
-
Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort.Nat Commun. 2024 Aug 7;15(1):6728. doi: 10.1038/s41467-024-51193-0. Nat Commun. 2024. PMID: 39112527 Free PMC article.
-
Social drivers in atrial fibrillation occurrence, screening, treatment, and outcomes: systematic-narrative hybrid review.Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv50-iv60. doi: 10.1093/eurheartjsupp/suae073. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099579 Free PMC article.
-
Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.BMJ. 2024 Apr 17;385:e077209. doi: 10.1136/bmj-2023-077209. BMJ. 2024. PMID: 38631726 Free PMC article.
-
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.Eur Heart J. 2024 May 27;45(20):1819-1827. doi: 10.1093/eurheartj/ehae198. Eur Heart J. 2024. PMID: 38606837 Free PMC article.
References
-
- Magnussen C, Niiranen TJ, Ojeda FM, et al. BiomarCaRE Consortium Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation 2017;136:1588-97. 10.1161/CIRCULATIONAHA.117.028981. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous